Literature DB >> 21717368

MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia.

Yi Yang1, Gary A Rosenberg.   

Abstract

The blood-brain barrier (BBB) has become a major focus of attention in cerebral pathophysiology and disease progression in the central nervous system. Endothelial tight junctions, the basal lamina, and perivascular astrocytes are jointly referred to as BBB or neurovascular unit. Around the cerebral endothelial cells is the basal lamina composed primarily of laminin, fibronectin, and heparan sulfate. The basal lamina provides a structural barrier to extravasation of cellular blood elements and anchors endothelial cells to astrocytes. Barriers limiting transport into and out of the brain are found at the tight junction proteins and at the basal lamina. The relative contribution of these two sites has not been studied, but it is likely that both are disrupted to some extent in various injury scenarios. We have shown that activation of matrix metalloproteinases (MMPs) opens the BBB by degrading tight junction proteins (claudin-5 and occludin) and increases BBB permeability after stroke, and that an MMP inhibitor prevents degradation of tight junction proteins and attenuates BBB disruption.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717368      PMCID: PMC4950933          DOI: 10.1007/978-1-61779-185-7_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

Review 1.  The blood-brain barrier/neurovascular unit in health and disease.

Authors:  Brian T Hawkins; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

2.  Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5.

Authors:  Masaru Honda; Shinsuke Nakagawa; Kentaro Hayashi; Naoki Kitagawa; Keisuke Tsutsumi; Izumi Nagata; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2006-04-20       Impact factor: 5.046

3.  Occludin expression in microvessels of neoplastic and non-neoplastic human brain.

Authors:  M C Papadopoulos; S Saadoun; C J Woodrow; D C Davies; P Costa-Martins; R F Moss; S Krishna; B A Bell
Journal:  Neuropathol Appl Neurobiol       Date:  2001-10       Impact factor: 8.090

4.  Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells.

Authors:  S Liebner; U Kniesel; H Kalbacher; H Wolburg
Journal:  Eur J Cell Biol       Date:  2000-10       Impact factor: 4.492

5.  Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation.

Authors:  Karen S Mark; Thomas P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

6.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.

Authors:  Hartwig Wolburg; Karen Wolburg-Buchholz; Jörg Kraus; Gesa Rascher-Eggstein; Stefan Liebner; Stefan Hamm; Frank Duffner; Ernst-H Grote; Werner Risau; Britta Engelhardt
Journal:  Acta Neuropathol       Date:  2003-02-25       Impact factor: 17.088

7.  Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1.

Authors:  T Kanda; Y Numata; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

8.  Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression.

Authors:  Ken A Witt; Karen S Mark; Sharon Hom; Thomas P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-07       Impact factor: 4.733

9.  Occludin as a possible determinant of tight junction permeability in endothelial cells.

Authors:  T Hirase; J M Staddon; M Saitou; Y Ando-Akatsuka; M Itoh; M Furuse; K Fujimoto; S Tsukita; L L Rubin
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

10.  Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin.

Authors:  M Furuse; K Fujita; T Hiiragi; K Fujimoto; S Tsukita
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more
  55 in total

Review 1.  Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.

Authors:  Wei-Ye Liu; Zhi-Bin Wang; Li-Chao Zhang; Xin Wei; Ling Li
Journal:  CNS Neurosci Ther       Date:  2012-06-12       Impact factor: 5.243

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Non-pharmaceutical therapies for stroke: mechanisms and clinical implications.

Authors:  Fan Chen; Zhifeng Qi; Yuming Luo; Taylor Hinchliffe; Guanghong Ding; Ying Xia; Xunming Ji
Journal:  Prog Neurobiol       Date:  2014-01-07       Impact factor: 11.685

4.  Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO--MMP-9 Pathway.

Authors:  Hansen Chen; Binghe Guan; Xi Chen; Xingmiao Chen; Caiming Li; Jinhua Qiu; Dan Yang; Ke Jian Liu; Suhua Qi; Jiangang Shen
Journal:  Transl Stroke Res       Date:  2017-12-23       Impact factor: 6.829

5.  Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.

Authors:  Phil Lee; Jieun Kim; Rachel Williams; Rajat Sandhir; Eugene Gregory; William M Brooks; Nancy E J Berman
Journal:  Exp Neurol       Date:  2011-12-19       Impact factor: 5.330

6.  Role of lipocalin-2 in brain injury after intracerebral hemorrhage.

Authors:  Wei Ni; Mingzhe Zheng; Guohua Xi; Richard F Keep; Ya Hua
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

Review 7.  Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke.

Authors:  Ali Ehsan Sifat; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  AAPS J       Date:  2017-05-08       Impact factor: 4.009

8.  Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.

Authors:  Keisuke Toyoda; Kunihiko Tanaka; Shinsuke Nakagawa; Dinh Ha Duy Thuy; Kenta Ujifuku; Kensaku Kamada; Kentaro Hayashi; Takayuki Matsuo; Izumi Nagata; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2013-02-06       Impact factor: 5.046

Review 9.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

10.  Effects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.

Authors:  Xiang Fan; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2013-02-19       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.